-
-
-
In this study, there is no correlation between the risk of recurrent stroke and the size of a PFO, the magnitude of the right-to-left shunt, or the presence of an atrial septal aneurysm.
-
This is an open label extension of 306 subjects from a previously reported delayed-start phase III clinical trial of rasagiline in early Parkinson's disease. Clinical benefit observed at one year in the early vs. delayed-start arm was maintained over an average 3.6 ± 2.1 years observation, raising the question of whether earlier intervention with rasagiline results in better outcomes.
-
-
Pathological gambling related to dopamine replacement therapy in Parkinson's disease is associated with overactivity of a right hemisphere network that includes regions involved in impulse control, reward, motivation, and memory.
-
Statin use, regardless of drug type, reduces the risk of dementia in later life.
-
Biopsy of the clinically affected nerve gives the highest yield for the diagnosis of vasculitic neuropathy.
-
Spreading of stimulation current to non-motor regions of the subthalamic nucleus (STN) or surrounding fiber tracts could be responsible for cognitive declines after STN deep brain stimulation (DBS), especially during bilateral stimulation and during complex cognitive-motor dual task.
-
Drug combinations for hypertension; tenecteplase for out-of-hospital cardiac arrest; CAM most commonly used for back, neck, and arthritis pain; FDA Actions.
